Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies.

Petrelli F, Ghidini M, Ghidini A, Perego G, Cabiddu M, Khakoo S, Oggionni E, Abeni C, Hahne JC, Tomasello G, Zaniboni A.

Cancers (Basel). 2019 Aug 14;11(8). pii: E1174. doi: 10.3390/cancers11081174.

2.

Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies.

Tomasello G, Ghidini M, Costanzo A, Ghidini A, Russo A, Barni S, Passalacqua R, Petrelli F.

J Gastrointest Oncol. 2019 Apr;10(2):259-269. doi: 10.21037/jgo.2018.12.08.

3.

Adjuvant radiotherapy for Merkel cell carcinoma: A systematic review and meta-analysis.

Petrelli F, Ghidini A, Torchio M, Prinzi N, Trevisan F, Dallera P, De Stefani A, Russo A, Vitali E, Bruschieri L, Costanzo A, Seghezzi S, Ghidini M, Varricchio A, Cabiddu M, Barni S, de Braud F, Pusceddu S.

Radiother Oncol. 2019 May;134:211-219. doi: 10.1016/j.radonc.2019.02.015. Epub 2019 Feb 28. Review.

PMID:
31005218
4.

Timing of Adjuvant Chemotherapy and Survival in Colorectal, Gastric, and Pancreatic Cancer. A Systematic Review and Meta-Analysis.

Petrelli F, Zaniboni A, Ghidini A, Ghidini M, Turati L, Pizzo C, Ratti M, Libertini M, Tomasello G.

Cancers (Basel). 2019 Apr 17;11(4). pii: E550. doi: 10.3390/cancers11040550. Review.

5.

Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials.

Petrelli F, Ghidini A, Pedersini R, Cabiddu M, Borgonovo K, Parati MC, Ghilardi M, Amoroso V, Berruti A, Barni S.

Breast Cancer Res Treat. 2019 Apr;174(3):597-604. doi: 10.1007/s10549-019-05133-y. Epub 2019 Jan 18. Review.

PMID:
30659432
6.

Addition of radiotherapy to the primary tumour in oligometastatic NSCLC: A systematic review and meta-analysis.

Petrelli F, Ghidini A, Cabiddu M, Tomasello G, De Stefani A, Bruschieri L, Vitali E, Ghilardi M, Borgonovo K, Barni S, Trevisan F.

Lung Cancer. 2018 Dec;126:194-200. doi: 10.1016/j.lungcan.2018.11.017. Epub 2018 Nov 13. Review.

PMID:
30527187
7.

One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysis.

Inno A, Barni S, Ghidini A, Zaniboni A, Petrelli F.

Breast Cancer Res Treat. 2019 Jan;173(2):247-254. doi: 10.1007/s10549-018-5001-x. Epub 2018 Oct 13.

PMID:
30317424
8.

Prognostic and predictive role of elevated lactate dehydrogenase in patients with melanoma treated with immunotherapy and BRAF inhibitors: a systematic review and meta-analysis.

Petrelli F, Ardito R, Merelli B, Lonati V, Cabiddu M, Seghezzi S, Barni S, Ghidini A.

Melanoma Res. 2019 Feb;29(1):1-12. doi: 10.1097/CMR.0000000000000520.

PMID:
30308577
9.

A systematic review and meta-analysis of second-line therapies for treatment of mesothelioma.

Petrelli F, Ardito R, Conti B, Coinu A, Cabiddu M, Ghilardi M, Borgonovo K, Barni S, Ghidini A.

Respir Med. 2018 Aug;141:72-80. doi: 10.1016/j.rmed.2018.06.026. Epub 2018 Jun 30.

PMID:
30053976
10.

Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review.

Petrelli F, Comito T, Barni S, Pancera G, Scorsetti M, Ghidini A; SBRT for CRC liver metastases.

Radiother Oncol. 2018 Dec;129(3):427-434. doi: 10.1016/j.radonc.2018.06.035. Epub 2018 Jul 9. Review.

PMID:
29997034
11.

Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis.

Petrelli F, Ardito R, Ghidini A, Zaniboni A, Ghidini M, Barni S, Tomasello G.

Oncology. 2018;94(4):191-199. doi: 10.1159/000486338. Epub 2018 Jan 23. Review.

PMID:
29393280
12.

Clinical development of mTor inhibitors for renal cancer.

Ghidini M, Petrelli F, Ghidini A, Tomasello G, Hahne JC, Passalacqua R, Barni S.

Expert Opin Investig Drugs. 2017 Nov;26(11):1229-1237. doi: 10.1080/13543784.2017.1384813. Epub 2017 Oct 3. Review.

PMID:
28952411
13.

Second line with oxaliplatin- or irinotecan-based chemotherapy for gemcitabine-pretreated pancreatic cancer: A systematic review.

Petrelli F, Inno A, Ghidini A, Rimassa L, Tomasello G, Labianca R, Barni S; GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente) and Cremona Hospital.

Eur J Cancer. 2017 Aug;81:174-182. doi: 10.1016/j.ejca.2017.05.025. Review.

PMID:
28633088
14.

[Cetuximab in association with an oxaliplatin-based chemotherapy as first-line treatment of metastatic colorectal cancer.]

Petrelli F, Ghidini A, Zaniboni A.

Recenti Prog Med. 2017 Mar;108(3):128-135. doi: 10.1701/2656.27235. Review. Italian.

PMID:
28398406
15.

Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer: A Systematic Review and Pooled Analysis of 19 Trials.

Petrelli F, Comito T, Ghidini A, Torri V, Scorsetti M, Barni S.

Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):313-322. doi: 10.1016/j.ijrobp.2016.10.030. Epub 2016 Oct 24. Review.

PMID:
28068239
16.

Borderline resectable pancreatic cancer: More than an anatomical concept.

Petrelli F, Inno A, Barni S, Ghidini A, Labianca R, Falconi M, Reni M, Cascinu S; GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell’Apparato Digerente) and San Raffaele Hospital.

Dig Liver Dis. 2017 Feb;49(2):223-226. doi: 10.1016/j.dld.2016.11.010. Epub 2016 Dec 5.

PMID:
27931968
17.

Mitomycin-C+fluoropyrimidines in heavily pretreated metastatic colorectal cancer: a systematic review and evidence synthesis.

Petrelli F, Ghidini A, Inno A, Barni S.

Anticancer Drugs. 2016 Jul;27(6):488-95. doi: 10.1097/CAD.0000000000000363.

PMID:
27186954
18.

A systematic review of raltitrexed-based first-line chemotherapy in advanced colorectal cancer.

Barni S, Ghidini A, Coinu A, Borgonovo K, Petrelli F.

Anticancer Drugs. 2014 Nov;25(10):1122-8. doi: 10.1097/CAD.0000000000000133. Review.

PMID:
24869761
19.

Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens: Clinical outcome and biomarkers of efficacy.

Pietrantonio F, Perrone F, Biondani P, Maggi C, Lampis A, Bertan C, Venturini F, Tondulli L, Ferrari D, Ricci V, Villa F, Barone G, Bianco N, Ghidini A, Bossi I, Fanetti G, Di Bartolomeo M, de Braud F.

Cancer Biol Ther. 2013 Dec;14(12):1098-103. doi: 10.4161/cbt.26343. Epub 2013 Sep 4.

20.

Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: a multi-institutional retrospective analysis.

Garassino MC, Torri V, Michetti G, Lo Dico M, La Verde N, Aglione S, Mancuso A, Gallerani E, Galetta D, Martelli O, CollovĂ  E, Fatigoni S, Ghidini A, Saggia C, Bareggi C, Rossi A, Farina G, Thatcher N, Blackhall F, Lorigan P, Califano R.

Lung Cancer. 2011 Jun;72(3):378-83. doi: 10.1016/j.lungcan.2010.09.009. Epub 2010 Oct 15.

PMID:
20950888

Supplemental Content

Loading ...
Support Center